Page last updated: 2024-08-24

meglumine antimoniate and Infarct

meglumine antimoniate has been researched along with Infarct in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Affronti, M; Di Rosa, S; Malta, R; Peralta, S; Renda, M; Rini, GB; Savalli, F; Scardavi, M; Trifiró, G	1

Other Studies

1 other study(ies) available for meglumine antimoniate and Infarct

Article	Year
Acute abdominal pain during therapy with glucantim: splenic infarct or excessive splenic enlargement? Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl Topics: Abdominal Pain; Adolescent; Antiprotozoal Agents; Diagnosis, Differential; Fatal Outcome; Humans; Infarction; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Spleen; Splenomegaly; Treatment Outcome	1989

Article

Year

Acute abdominal pain during therapy with glucantim: splenic infarct or excessive splenic enlargement?

Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl

Topics: Abdominal Pain; Adolescent; Antiprotozoal Agents; Diagnosis, Differential; Fatal Outcome; Humans; Infarction; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Spleen; Splenomegaly; Treatment Outcome

1989